Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Alexza Pharmaceuticals, Inc.
Age
18–65
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Subjects who have migraine headache with or without aura (diagnosis according to International Headache Society guidelines) for at least 6 months, who have been pain free for at least 48 hours since the end of their last migraine attack, who have a pain rating of Moderate or Severe prior to dosing.
You may not be if
Subjects who have taken any other migraine or pain medication within 48 hours of randomization, with a history of allergy or intolerance to phenothiazines and related drugs, or are considered by the investigator, for any reason, to be an unsuitable candidate for receiving prochlorperazine, or unable to use the inhalation device, must be excluded.
Clareo Health | Staccato Prochlorperazine in Migraine (in Clinic)
